MARATTO

article · International Journal of Nanomaterials Nanotechnology and Nanomedicine

Silk Fibroin Nanoparticles (SFNs) for nanoencapsulation of bioactive molecules

20243 citationsOpen accessUniversity of Tunis El Manar

Abstract

Silk Fibroin Nanoparticles (SFNs) have become a reliable and effective biomaterial for nanoencapsulation in several fields such as food, biocosmetics, and medical products due to their physicochemical characteristics. Recently, it has also been developed for application in biomaterials and regenerative medicine, also for cellular nanoencapsulation, and drug delivery systems. Silk fibroin is a natural biomaterial relatively not expensive, biocompatible, eco-friendly, and non-toxic FDA-approved protein derived from the Bombyx mori silkworm cocoon. Fibroin has recently been investigated in the drug field carrier for controlled release. Their application has also become widespread in regenerating therapy as a support for regenerating tissues, as well as in nanomedicine. Furthermore, SFNs have been studied as a carrier for single bioactive molecules such as resveratrol, quercetin, or curcumin for volatile compounds, and for vegetal oils in the form of emulsions. The nanoencapsulation of bioactive compounds in a biopolymer of silk fibroin can be efficiently protected from harmful environmental agents like light, oxygen, or water. The present review reveals that silk fibroin nanoparticles constitute a useful biomaterial to protect, stabilize, and deliver bioactive components. This is a promising combination in safety food, biocosmetic products, nanomedicine, and healthcare.

Research topics

  • Silk-based biomaterials and applications
  • Phytochemical compounds biological activities
  • Bone Tissue Engineering Materials

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.17352/2455-3492.000057

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.